Southon A, Szostak K, Acevedo KM, Dent KA, Volitakis I, Belaidi AA et al (2020) CuII (atsm) inhibits ferroptosis: implications for treatment of neurodegenerative disease
Supplements do show promise, but relying solely on them without addressing other lifestyle factors may produce limited results
Short for Body Protection Compound-157, its one of the most frequently referenced peptides in tissue-repair research
Insulin-like Growth Factor-1 Long Arginine 3, also known as IGF-1 LR3, is a modified, synthetic version of insulin-like Growth Factor-1
It is used for dilution and reconstitution of research peptides in laboratory settings
In a study of adipose mass, growth therapy treatment for 26 weeks resulted in: Subcutaneous fat mass decreased by 13% Intra-abdominal fat mass reduced by 30% Lean body mass increased by 3-11% Aerobic function improved by 11-19% Muscle strength increased by 7-19% These changes continued during one year of treatment resulting in a 22% reduction in overall fat mass and a 61% reduction in belly fat